Shenzhen Salubris Pharmaceuticals (SHE:002294) submitted an updated application for the offering and listing on the Hong Kong Stock Exchange, according to a Friday disclosure on the Shenzhen bourse.
The pharmaceutical company submitted its first Hong Kong listing application in February.